Cebi Hakan, Akşahin Ertuğrul, Yüksel Halil Yalçin, Celebi Levent, Aktekin Cem Nuri, Hapa Onur, Muratli Hasan Hilmi, Biçimoğlu Ali
Department of Orthopedics and Traumatology, Ankara Numune Training and Research Hospital, Turkey.
Eklem Hastalik Cerrahisi. 2010 Aug;21(2):91-7.
The relation between serum vascular endothelial growth factor (VEGF) level and bone mineral density (BMD) value was evaluated to investigate the role of VEGF at etiopathogenesis of the osteoporosis.
Bone scanning with dual energy X-ray absorptiometry (DEXA) was performed on a total of 276 patients more than 40 years of age between September 2007 and January 2008 in our hospital's radiology department. A total of 88 patients (44 females; mean age 62.8+/-12.2 year, 44 males; mean age 58.7+/-12.1 year) meeting the study criteria were included. These patients formed four groups; osteoporotic male patients (group MO, n=22, BMD< -2.5), normal males (group MN, n=22, BMD> -1), osteoporotic female patients (group FO, n=22, BMD< -2.5), and normal females (group FN, n=22, BMD> -1). Bone mineral density measurements were performed with DEXA. Serum VEGF level was determined by the endogenous human ELISA kit. The relationships between body mass index (BMI), age, BMD and serum VEGF levels were analyzed.
The difference between male and female participants in terms of serum VEGF levels was not statistically significant (p>0.05). The differences in terms of mean VEGF values between the MO and MN groups and the FO and FN groups were not statistically significant (p>0.05). In MN cases, BMD was negatively correlated with VEGF levels (p<0.05). In MO group, the correlation between BMD and serum VEGF levels was not statistically significant (p>0.05).
Although the plasma levels of osteoporotic subjects are relatively higher than in the normal groups, this was not statistically significant in either male or female subjects. The small sample size could be a reason for this insignificance. The negative correlation between serum VEGF and BMD levels in the MN group was not present in the MO group. When the various effects of serum VEGF on bone metabolism are taken into account, to clarify the pathophysiology of male osteoporosis, this association between BMD values and VEGF in male population must be investigated in further studies.
评估血清血管内皮生长因子(VEGF)水平与骨密度(BMD)值之间的关系,以探讨VEGF在骨质疏松症发病机制中的作用。
2007年9月至2008年1月期间,在我院放射科对总共276例年龄超过40岁的患者进行了双能X线吸收法(DEXA)骨扫描。纳入了88例符合研究标准的患者(44例女性;平均年龄62.8±12.2岁,44例男性;平均年龄58.7±12.1岁)。这些患者分为四组:骨质疏松男性患者(MO组,n = 22,BMD < -2.5),正常男性(MN组,n = 22,BMD > -1),骨质疏松女性患者(FO组,n = 22,BMD < -2.5),以及正常女性(FN组,n = 22,BMD > -1)。使用DEXA进行骨密度测量。通过人内源性ELISA试剂盒测定血清VEGF水平。分析体重指数(BMI)、年龄、BMD与血清VEGF水平之间的关系。
男性和女性参与者的血清VEGF水平差异无统计学意义(p > 0.05)。MO组与MN组以及FO组与FN组之间的平均VEGF值差异无统计学意义(p > 0.05)。在MN组中,BMD与VEGF水平呈负相关(p < 0.05)。在MO组中,BMD与血清VEGF水平之间的相关性无统计学意义(p > 0.05)。
尽管骨质疏松患者的血浆水平相对高于正常组,但在男性或女性受试者中这均无统计学意义。样本量小可能是这种无显著性差异的原因。MO组不存在MN组中血清VEGF与BMD水平之间的负相关。考虑到血清VEGF对骨代谢的各种影响,为阐明男性骨质疏松症的病理生理学,必须在进一步研究中调查男性人群中BMD值与VEGF之间的这种关联。